2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Insurance Revenue | 9,469,000 | 13.374% | 17,514,000 | 16,319,000 | -- | -- |
Interest Income | 3,966,000 | 2.960% | 7,820,000 | 7,267,000 | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | -- | -- | -- | -- | 37,123,000 | 35,780,000 |
Net Premium Income | -- | -- | -- | -- | 34,444,000 | 33,328,000 |
Investment Income/(Loss) | 1,227,000 | -65.992% | 4,941,000 | (38,647,000) | 8,660,000 | 8,159,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | 2,348,000 | 1,386,000 |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | 1,161,000 | 7,294,000 |
Other Income/(Loss) | 212,000 | 4.433% | 408,000 | 1,579,000 | 912,000 | 192,000 |
Total Revenues | 14,874,000 | -7.125% | 30,683,000 | (13,482,000) | 47,525,000 | 50,359,000 |
Insurance Service Expenses | (6,222,000) | 16.430% | (12,078,000) | (10,434,000) | -- | -- |
Net Expenses from Reinsurance Contracts | (221,000) | 9.406% | (345,000) | (419,000) | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | (3,279,000) | -48.060% | (10,456,000) | 30,957,000 | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | 61,000 | 10.909% | 65,000 | 67,000 | -- | -- |
Net Impairment Loss | 1,000 | -- | (195,000) | (233,000) | -- | -- |
Other Expenses | (1,445,000) | 0.278% | (2,843,000) | (2,281,000) | (39,046,000) | (43,072,000) |
Other Non-operating Items | 0 | -- | 0 | 0 | -- | -- |
Share of results of Associates & JCEs | 73,000 | -- | (267,000) | (121,000) | (11,000) | (17,000) |
Profit / (Loss) before Taxation | 3,842,000 | 46.585% | 4,564,000 | 4,054,000 | 8,468,000 | 7,270,000 |
Taxation | (522,000) | 42.623% | (783,000) | (689,000) | (991,000) | (1,491,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (6,000) | 20.000% | (17,000) | (34,000) | (50,000) | 0 |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 3,314,000 | 47.289% | 3,764,000 | 3,331,000 | 7,427,000 | 5,779,000 |
2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
Depreciation & Amortisation | 225,000 | 16.580% | 416,000 | 391,000 | 407,000 | 407,000 |
Directors' Emoluments | -- | -- | 17,638 | 17,484 | 18,650 | 31,966 |
2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
EPS (cts) | 29.530 | 52.295% | 33.000 | 28.000 | 62.000 | 48.000 |
DPS (cts) | 5.711 | -- | 20.630 | 19.579 | 18.663 | 17.440 |
Dividend Payout Ratio (%) | 19.339% | -- | 62.516% | 69.926% | 30.101% | 36.334% |
Cash flow per share ($) | -- | -- | 0.948 | 0.827 | 0.324 | 0.195 |
NBV per share ($) | 3.515 | -- | 3.606 | 3.792 | 4.999 | 5.225 |
Remarks: | Real time quote last updated: 14/11/2024 12:10 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders ($) | USD 3,314,000,000 |
%Change | 47.289% |
EPS / (LPS) | USD 0.295 |
NBV Per Share ($) | USD 3.515 |